Generali Asset Management SPA SGR Acquires Shares of 33,037 Avantor, Inc. (NYSE:AVTR)

Generali Asset Management SPA SGR bought a new stake in Avantor, Inc. (NYSE:AVTR - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm bought 33,037 shares of the company's stock, valued at approximately $696,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. MassMutual Private Wealth & Trust FSB boosted its position in shares of Avantor by 99.5% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company's stock worth $26,000 after acquiring an additional 625 shares in the last quarter. Smartleaf Asset Management LLC increased its stake in shares of Avantor by 106.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company's stock valued at $34,000 after purchasing an additional 830 shares during the last quarter. Global Retirement Partners LLC raised its holdings in shares of Avantor by 76.7% during the 4th quarter. Global Retirement Partners LLC now owns 2,459 shares of the company's stock worth $52,000 after buying an additional 1,067 shares in the last quarter. UMB Bank n.a. grew its position in Avantor by 56.3% in the fourth quarter. UMB Bank n.a. now owns 2,981 shares of the company's stock valued at $63,000 after acquiring an additional 1,074 shares during the last quarter. Finally, AlphaQuest LLC acquired a new position in Avantor during the fourth quarter worth about $65,000. 95.08% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, CAO Steven W. Eck sold 4,907 shares of the company's stock in a transaction on Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total value of $86,019.71. Following the completion of the sale, the chief accounting officer now owns 40,604 shares in the company, valued at $711,788.12. This represents a 10.78 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP James Bramwell sold 3,758 shares of the firm's stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total transaction of $65,877.74. Following the transaction, the executive vice president now directly owns 87,379 shares in the company, valued at $1,531,753.87. The trade was a 4.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.50% of the company's stock.

Remove Ads

Analyst Ratings Changes

AVTR has been the topic of a number of research analyst reports. Citigroup reduced their price target on shares of Avantor from $22.00 to $18.00 and set a "neutral" rating on the stock in a research note on Tuesday, March 4th. Barclays decreased their target price on shares of Avantor from $26.00 to $23.00 and set an "overweight" rating on the stock in a research note on Monday, February 10th. Royal Bank of Canada dropped their price target on Avantor from $33.00 to $31.00 and set an "outperform" rating for the company in a research note on Monday, February 10th. Cowen restated a "buy" rating on shares of Avantor in a research report on Tuesday, March 18th. Finally, UBS Group reaffirmed a "neutral" rating and issued a $25.00 price objective (down previously from $29.00) on shares of Avantor in a research note on Friday, January 17th. Three equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company's stock. Based on data from MarketBeat.com, Avantor has an average rating of "Moderate Buy" and a consensus price target of $25.50.

Avantor Stock Down 1.0 %

Shares of AVTR traded down $0.16 during trading hours on Tuesday, reaching $16.33. The stock had a trading volume of 7,241,965 shares, compared to its average volume of 6,326,092. The company has a market capitalization of $11.12 billion, a price-to-earnings ratio of 15.70, a P/E/G ratio of 1.55 and a beta of 1.30. The firm has a 50-day simple moving average of $18.87 and a 200 day simple moving average of $21.63. The company has a current ratio of 1.07, a quick ratio of 0.70 and a debt-to-equity ratio of 0.54. Avantor, Inc. has a 12 month low of $15.37 and a 12 month high of $28.00.

Avantor (NYSE:AVTR - Get Free Report) last released its quarterly earnings data on Wednesday, February 12th. The company reported $0.27 earnings per share for the quarter, beating analysts' consensus estimates of $0.26 by $0.01. Avantor had a net margin of 10.49% and a return on equity of 12.17%. During the same period last year, the business earned $0.22 EPS. Equities research analysts predict that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.